Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analy

Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analy

Item
http://www.wikidata.org/entity/Q27694496
Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritisRefining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous TocilizumabAn expanding role for interleukin-1 blockade from gout to cancer.Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry.Efficacy of biological agents administered as monotherapy in rheumatoid arthritis: a Bayesian mixed-treatment comparison analysis.Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activity.Use of Anti-Tumor Necrosis Factor Therapy: A Retrospective Study of Monotherapy and Adherence to Combination Therapy with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs.Tocilizumab as monotherapy or combination therapy for treating active rheumatoid arthritis: a meta-analysis of efficacy and safety reported in randomized controlled trials.Type I IFNs as biomarkers in rheumatoid arthritis: towards disease profiling and personalized medicine.Biologic monotherapy in the treatment of rheumatoid arthritis.Tofacitinib with conventional synthetic disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient-reported outcomes from a Phase 3 randomized controlled trial.Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEA.Efficacy and safety of adalimumab by intra-articular injection for moderate to severe knee osteoarthritis: An open-label randomized controlled trial.The Efficacy and Safety of Mainstream Medications for Patients With cDMARD-Naïve Rheumatoid Arthritis: A Network Meta-Analysis.Efficacy of Monotherapy with Biologics and JAK Inhibitors for the Treatment of Rheumatoid Arthritis: A Systematic Review
P2860

Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs--a systematic review and network meta-analy

Item
http://www.wikidata.org/entity/Q27694496
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Comparative efficacy of biolog ...... review and network meta-analy
@en
Comparative efficacy of biolog ...... review and network meta-analy
@nl
type
label
Comparative efficacy of biolog ...... review and network meta-analy
@en
Comparative efficacy of biolog ...... review and network meta-analy
@nl
prefLabel
Comparative efficacy of biolog ...... review and network meta-analy
@en
Comparative efficacy of biolog ...... review and network meta-analy
@nl
P1433
P1476
P2093
P275
P2860
P2888
P304
P31
P3181
P356
P478
P50
P5008
P577
P5875
P6179
P698
P921
P932
P3181
P356
P1433
P1476
Comparative efficacy of biolog ...... view and network meta-analysis
@en
P2093
P275
P2860
P2888
P304
P31
P3181
P356
P478
P50
P5008
P577
P5875
P6179
P698
P921
P932